Xu CJ - Search Results

1

[In vitro experimental study of gene therapy for ovarian cancer with thymidine kinase gene of herpes simplex virus mediated by a non-viral GE7 delivery system].

Liu XJ, Xu CJ, Jin ZJ, Liu Y, Dai FH, Han JS, Tian PK, Gu JR. Liu XJ, et al. Among authors: xu cj. Zhonghua Fu Chan Ke Za Zhi. 2003 Oct;38(10):621-4. Zhonghua Fu Chan Ke Za Zhi. 2003. PMID: 14728867 Chinese.

2

[Study of GE7-transferring system mediated beta-galactosidase gene transfer in a rat model of ovarian tumor by intraarterial route].

Jiang W, Xu CJ, Shao ZM, Zhou WJ, Liu XX, Tian PK, Zhu JD, Gu JR. Jiang W, et al. Among authors: xu cj. Zhonghua Fu Chan Ke Za Zhi. 2004 May;39(5):338-41. Zhonghua Fu Chan Ke Za Zhi. 2004. PMID: 15196419 Chinese.

3

Enhanced efficiency and specificity of ovarian cancer gene therapy in rats with a novel nonviral gene delivery system (GE7) via intraovarian artery perfusion approach.

Jiang W, Xu CJ, Shao ZM, Zhou WJ, Ye B, Tian PK, Zhu JD, Gu JR. Jiang W, et al. Among authors: xu cj. Cancer Gene Ther. 2005 Oct;12(10):810-7. doi: 10.1038/sj.cgt.7700845. Cancer Gene Ther. 2005. PMID: 15905861

4

[Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].

Kang Y, Xu CJ, Liu XS, Wu CQ, Zhong CP, Gu JR. Kang Y, et al. Among authors: xu cj. Ai Zheng. 2005 Aug;24(8):909-14. Ai Zheng. 2005. PMID: 16086864 Chinese.

5

[Controlled live dendritic cell vaccine mediates potent antitumor immune responses].

Kang Y, Xu CJ, Liu XS, Zhang XH, Wu CQ, Zhong CP, Gu JR. Kang Y, et al. Among authors: xu cj. Zhonghua Fu Chan Ke Za Zhi. 2004 Oct;39(10):669-74. Zhonghua Fu Chan Ke Za Zhi. 2004. PMID: 16144563 Chinese.

6

[Primary study of vasculogenic mimicry induced by hypoxia in epithelial ovarian carcinoma].

Yao LQ, Feng YJ, Ding JX, Xu CJ, Jin HY, Yin LH. Yao LQ, et al. Among authors: xu cj. Zhonghua Fu Chan Ke Za Zhi. 2005 Oct;40(10):662-5. Zhonghua Fu Chan Ke Za Zhi. 2005. PMID: 16277894 Chinese.

7

A novel strategy to compensate the disadvantages of live vaccine using suicide-gene system and provide better antitumor immunity.

Kang Y, Xu CJ, Wu CQ, Liu XS, Zhong CP, Zhang XH, Qiao SY, Gu JR. Kang Y, et al. Among authors: xu cj. Vaccine. 2006 Mar 15;24(12):2141-50. doi: 10.1016/j.vaccine.2005.11.023. Epub 2005 Dec 5. Vaccine. 2006. PMID: 16368168

8

[Suicidal cancer vaccine enhances anti-tumor immunotherapeutic effect and its safety in the treatment of ovarian cancer].

Kang Y, Xu CJ, Liu XS, Shao ZM, Ou ZL, Luo JM, Wu CQ, Zhong CP, Gu JR. Kang Y, et al. Among authors: xu cj. Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):654-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17274368 Chinese.

9

[Preparation and in vitro targeting of follicle stimulating hormone polypeptide modified nanoparticles].

Zhang XY, Chen J, Gao XL, Sun H, Xu CJ. Zhang XY, et al. Among authors: xu cj. Zhonghua Fu Chan Ke Za Zhi. 2008 Jul;43(7):533-7. Zhonghua Fu Chan Ke Za Zhi. 2008. PMID: 19080519 Chinese.

10

[Monitoring of methotrexate concentrations in lung and other tissues of rat through internal iliac artery infusion].

Lu JQ, Zheng JH, Zhang L, Xu CJ. Lu JQ, et al. Among authors: xu cj. Zhonghua Fu Chan Ke Za Zhi. 2008 Dec;43(12):892-6. Zhonghua Fu Chan Ke Za Zhi. 2008. PMID: 19134325 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters